Lara S. Kallander

4-Aryl-1,2,3-triazole:  A Novel Template for a Reversible Methionine Aminopeptidase 2 Inhibitor, Optimized To Inhibit Angiogenesis in Vivo

Lara S. Kallander, Qing Lü, Wenfang Chen et al. · Journal of Medicinal Chemistry · 2005 · 188 citations · Full text

Mouse Matrigel Model, Endothelial Cell Growth, Pharmacotherapy +17

Inhibition of the Cardiomyocyte-Specific Kinase TNNI3K Limits Oxidative Stress, Injury, and Adverse Remodeling in the Ischemic Heart

Ronald J. Vagnozzi, Gregory J. Gatto, Lara S. Kallander et al. · Science Translational Medicine · 2013 · 70 citations · Full text

A Versatile Enantioselective Strategy Toward<scp>l</scp>-<i>C</i>-Nucleosides:  A Total Synthesis of<scp>l</scp>-Showdomycin

Barry M. Trost, Lara S. Kallander · The Journal of Organic Chemistry · 1999 · 62 citations

Combinatorial Chemistry, Asymmetric Catalysis, Medicinal Chemistry +13

Identification of Purines and 7-Deazapurines as Potent and Selective Type I Inhibitors of Troponin I-Interacting Kinase (TNNI3K)

Brian G. Lawhorn, Joanne Philp, Yongdong Zhao et al. · Journal of Medicinal Chemistry · 2015 · 46 citations · Full text

Medicinal Chemistry, Pharmaceutical Chemistry, Signal Transduction +14

Discovery of non-steroidal mifepristone mimetics: Pyrazoline-based PR antagonists

David G. Jones, Xi Liang, Eugene L. Stewart et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 33 citations · Full text

Medicine, Mechanism Of Action, Pharmacological Agent +4